Hear from the experts pioneering allogeneic drug development including: Atara BiotherapeuticsAllogeneCelyad and Kuur Therapeutics, who will be addressing:  

  • Translatable analysis to increase depth of response 
  • Process innovation to lower cost-of-goods and meet regulatory standards 
  • Define characteristics for optimal donor selection to achieve high quality starting material  

… and much more! 

Key speakers include: 

Barbra Sasu



Karl-Johan Malmberg


Karolinska Institute

Lior Raviv

VP, Development & Operations


Olive Sturtevant

Senior Administrative Director of Connell & O’Reilly Families, Cell Manipulation Core Facility

Dana Farber Cancer Institute

9:30 - 5:00 EDT | 6:30 - 2:00 PDT - All times are shown in EDT

9:30 am Virtual Coffee Networking

10:00 am Chair’s Opening Remarks

10:05 am Industry Leader’s Fireside Chat


An executive panel discussion from the C-level leaders of the field to set the scene on allogeneic cell  therapy development. Ask your questions live to understand the expert’s thoughts on key topics including gene engineering, cell persistence, ultimate donor source, optimal cryopreservation, and scalable manufacture.

11:00 am Optimizing Allogeneic Cell Therapy Manufacturing with Next Generation Ancillary Materials and Services


  • Bringing liquid cGMP cytokines and growth factors into functionally-closed, single-use systems for ex vivo applications
  • Improving safety, batch-to-batch consistency and supply through virus inactivated blood products and media supplements at commercial scale
  • Strategic approaches to manufacturing high quality cGMP plasmid DNA: Aligning plasmid development with internal clinical development timelines to reduce costs and optimize material quality

11:30 am Speed Networking

12:00 pm Refreshment Break


Take this time to go for a walk, make a coffee, or reach out to your colleagues on the online chat feature and schedule a video call!

2:00 pm Refreshment Break

4:10 pm Closing Remarks

4:15 pm Close of Day 1